StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)

Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –

Liquidia price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Liquidia's price to sales ratio was 10.9× on Nov 11, 2026, against 40.9× a year earlier. Over the last 5 years it ranged from 6.0× to 123.0×, with a median of 30.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.9×−32.4
2025Dec 31, 202543.3×−20.4
2024Dec 31, 202463.7×+21.1
2023Dec 29, 202342.6×+12.8
2022Dec 30, 202229.8×+5.4
2021Dec 31, 202124.4×+14.1
2020Dec 31, 202010.3×–

More Liquidia figures

See a number that looks wrong?